Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cross Infection | 19 | 2024 | 1422 | 1.170 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 17 | 2023 | 695 | 1.080 |
Why?
|
Staphylococcal Infections | 15 | 2023 | 1400 | 0.900 |
Why?
|
Chlorhexidine | 7 | 2023 | 160 | 0.750 |
Why?
|
Mupirocin | 6 | 2023 | 55 | 0.580 |
Why?
|
Infection Control | 9 | 2024 | 983 | 0.580 |
Why?
|
Baths | 5 | 2023 | 53 | 0.550 |
Why?
|
Adverse Drug Reaction Reporting Systems | 2 | 2013 | 494 | 0.410 |
Why?
|
Carrier State | 7 | 2019 | 522 | 0.370 |
Why?
|
California | 16 | 2018 | 1431 | 0.370 |
Why?
|
Valproic Acid | 1 | 2013 | 443 | 0.350 |
Why?
|
Bacteremia | 5 | 2019 | 978 | 0.340 |
Why?
|
Hospitals | 9 | 2018 | 3881 | 0.300 |
Why?
|
Drugs, Generic | 1 | 2013 | 448 | 0.290 |
Why?
|
Disease Outbreaks | 4 | 2024 | 1747 | 0.270 |
Why?
|
Intensive Care Units | 8 | 2023 | 3743 | 0.240 |
Why?
|
Urinary Tract Infections | 2 | 2024 | 802 | 0.230 |
Why?
|
Hospitals, Community | 4 | 2024 | 365 | 0.230 |
Why?
|
Iodophors | 1 | 2023 | 7 | 0.230 |
Why?
|
Drug Resistance, Multiple, Bacterial | 4 | 2024 | 585 | 0.220 |
Why?
|
Anti-Infective Agents, Local | 4 | 2023 | 247 | 0.220 |
Why?
|
Anti-Bacterial Agents | 8 | 2024 | 7405 | 0.210 |
Why?
|
Anticonvulsants | 1 | 2013 | 1911 | 0.210 |
Why?
|
Medical Order Entry Systems | 2 | 2024 | 521 | 0.200 |
Why?
|
Patient Discharge | 5 | 2015 | 3441 | 0.200 |
Why?
|
Nursing Homes | 3 | 2015 | 1083 | 0.200 |
Why?
|
Quality Indicators, Health Care | 1 | 2011 | 1790 | 0.190 |
Why?
|
Population Surveillance | 1 | 2011 | 2599 | 0.190 |
Why?
|
Patient Transfer | 6 | 2013 | 793 | 0.170 |
Why?
|
Computer Simulation | 4 | 2013 | 6225 | 0.160 |
Why?
|
Drug Resistance, Bacterial | 2 | 2016 | 1048 | 0.150 |
Why?
|
Surgical Wound Infection | 2 | 2018 | 1530 | 0.140 |
Why?
|
Anti-Infective Agents | 1 | 2023 | 983 | 0.130 |
Why?
|
Sepsis | 2 | 2023 | 2586 | 0.130 |
Why?
|
Disinfection | 2 | 2015 | 207 | 0.120 |
Why?
|
Acinetobacter Infections | 1 | 2014 | 72 | 0.110 |
Why?
|
Administration, Intranasal | 3 | 2023 | 476 | 0.110 |
Why?
|
Interinstitutional Relations | 2 | 2013 | 236 | 0.110 |
Why?
|
Health Maintenance Organizations | 2 | 2013 | 658 | 0.110 |
Why?
|
Hysterectomy | 1 | 2018 | 856 | 0.110 |
Why?
|
Digestive System Surgical Procedures | 1 | 2018 | 571 | 0.110 |
Why?
|
Disinfectants | 1 | 2014 | 129 | 0.110 |
Why?
|
Hospital Shared Services | 1 | 2012 | 16 | 0.110 |
Why?
|
Candidiasis | 1 | 2015 | 365 | 0.110 |
Why?
|
Disease Notification | 1 | 2013 | 95 | 0.110 |
Why?
|
Catheter-Related Infections | 1 | 2016 | 273 | 0.100 |
Why?
|
Vancomycin Resistance | 1 | 2013 | 125 | 0.100 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2014 | 264 | 0.100 |
Why?
|
Pneumonia | 1 | 2024 | 2142 | 0.100 |
Why?
|
Patient Readmission | 4 | 2015 | 3268 | 0.100 |
Why?
|
Enterococcus | 1 | 2013 | 159 | 0.100 |
Why?
|
Health Facility Administration | 1 | 2011 | 29 | 0.100 |
Why?
|
Product Surveillance, Postmarketing | 2 | 2013 | 452 | 0.100 |
Why?
|
Hospitals, County | 1 | 2011 | 17 | 0.090 |
Why?
|
Length of Stay | 5 | 2024 | 6420 | 0.090 |
Why?
|
Colon | 1 | 2018 | 1791 | 0.090 |
Why?
|
Risk | 2 | 2013 | 9614 | 0.090 |
Why?
|
Cost Savings | 1 | 2014 | 912 | 0.080 |
Why?
|
Cluster Analysis | 2 | 2015 | 2706 | 0.080 |
Why?
|
Data Mining | 1 | 2013 | 552 | 0.070 |
Why?
|
Antifungal Agents | 1 | 2013 | 753 | 0.070 |
Why?
|
Nasal Cavity | 3 | 2014 | 304 | 0.070 |
Why?
|
Genetics, Population | 1 | 2012 | 935 | 0.070 |
Why?
|
Epidemiologic Methods | 1 | 2011 | 1336 | 0.070 |
Why?
|
Middle Aged | 16 | 2024 | 220835 | 0.060 |
Why?
|
Clostridium Infections | 1 | 2011 | 557 | 0.060 |
Why?
|
Time Factors | 4 | 2014 | 39953 | 0.060 |
Why?
|
Aged | 13 | 2024 | 169266 | 0.050 |
Why?
|
Staphylococcus aureus | 2 | 2023 | 1450 | 0.050 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2013 | 1413 | 0.050 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2013 | 1394 | 0.050 |
Why?
|
Humans | 30 | 2024 | 761098 | 0.050 |
Why?
|
Adult | 12 | 2024 | 221083 | 0.050 |
Why?
|
Male | 16 | 2024 | 360675 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2013 | 5249 | 0.050 |
Why?
|
Linear Models | 1 | 2011 | 5869 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12058 | 0.050 |
Why?
|
Female | 16 | 2024 | 392458 | 0.050 |
Why?
|
Pneumonia, Bacterial | 1 | 2024 | 316 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2018 | 80673 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2013 | 2045 | 0.040 |
Why?
|
Cohort Studies | 5 | 2018 | 41486 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 3086 | 0.040 |
Why?
|
Pilot Projects | 1 | 2013 | 8639 | 0.040 |
Why?
|
Software | 1 | 2013 | 4433 | 0.040 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58946 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7400 | 0.040 |
Why?
|
Incidence | 2 | 2011 | 21357 | 0.030 |
Why?
|
Clostridium | 1 | 2015 | 100 | 0.030 |
Why?
|
Bacteriuria | 1 | 2015 | 102 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5333 | 0.030 |
Why?
|
Acinetobacter | 1 | 2014 | 39 | 0.030 |
Why?
|
Candida | 1 | 2015 | 172 | 0.030 |
Why?
|
Young Adult | 4 | 2015 | 59199 | 0.030 |
Why?
|
beta-Lactam Resistance | 1 | 2014 | 73 | 0.030 |
Why?
|
Administration, Topical | 1 | 2016 | 703 | 0.030 |
Why?
|
United States | 5 | 2024 | 72337 | 0.030 |
Why?
|
Klebsiella pneumoniae | 1 | 2015 | 249 | 0.030 |
Why?
|
Health Facility Size | 1 | 2013 | 61 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2013 | 7873 | 0.030 |
Why?
|
Genes, Bacterial | 1 | 2016 | 1073 | 0.030 |
Why?
|
Prospective Studies | 2 | 2014 | 54419 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2016 | 871 | 0.020 |
Why?
|
Prevalence | 3 | 2013 | 15717 | 0.020 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2013 | 342 | 0.020 |
Why?
|
Adolescent | 3 | 2015 | 88271 | 0.020 |
Why?
|
Vancomycin | 1 | 2013 | 503 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2016 | 1936 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2013 | 991 | 0.020 |
Why?
|
Hospital Administration | 1 | 2013 | 352 | 0.020 |
Why?
|
Pharmacoepidemiology | 1 | 2013 | 351 | 0.020 |
Why?
|
Medical Audit | 1 | 2010 | 453 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2011 | 1624 | 0.020 |
Why?
|
Hospital Costs | 1 | 2014 | 947 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2013 | 709 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2011 | 469 | 0.020 |
Why?
|
Disease Transmission, Infectious | 1 | 2013 | 561 | 0.020 |
Why?
|
Long-Term Care | 1 | 2011 | 630 | 0.020 |
Why?
|
Child | 2 | 2013 | 80134 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6067 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4739 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2012 | 2424 | 0.020 |
Why?
|
Hospitalization | 1 | 2024 | 10712 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2012 | 2218 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10552 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2012 | 3568 | 0.010 |
Why?
|
Mass Screening | 1 | 2014 | 5425 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7969 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2013 | 4813 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74219 | 0.010 |
Why?
|
Concepts
(130)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_